When couples face the diagnosis of cancer, women carry a larger emotional burden than menMarch 03, 2008In a couple where one of the partners is diagnosed with cancer, women are more consistently and severely distressed than men, regardless of whether they are the person with the disease or the healthy partner. The results of a research paper appearing in the Psychological Bulletin report that when a couple is faced with coping with a diagnosis of cancer, gender plays a greater role than who the patient is. For more than twenty-years, researchers have accumulated anecdotal and statistical evidence that has been inconclusive and even contradictory as to who carries the greater psychological burden in a couple struggling with the diagnosis of cancer, the patient or the spouse" The researchers from the University of Pennsylvania School of Medicine and the University Medical Center Groningen, in the Netherlands, conducted the exhaustive study that analyzed the findings of 43 studies from around the world that assessed distress in couples coping with cancer. "It is the gender that maters," said James C. Coyne MD, Professor of Psychology in Psychiatry at the University of Pennsylvania School of Medicine, a co-author of the published study. "Past studies focused on who has the cancer, not gender, and that explains the inconsistency in the findings," "In practical terms, breast cancer patients are going to be, on average, more distressed than their husbands; but the wives of prostate cancer patients are going to be, on average, more distressed than their husbands," said lead study author, Mariët Hagedoorn, Professor of health Psychology at the University Medical Center Groningen. Surprisingly, when researchers looked at anxiety in the general population or in patients recruited from waiting rooms of primary care practices, they found that the level of distress in couples facing the diagnosis of cancer was only "moderate" in comparison. "Only a minority of cancer patients suffer clinically significant distress," said Professor Hagedoorn. "The myth that all cancer patients are distressed gets in the way of getting the proper attention to those patients who do become significantly distressed and who could benefit from a clinical intervention." University of Pennsylvania School of Medicine |
|||||||||||||||||||||
| Related Cancer Patient Current Events and Cancer Patient News Articles NIH study reveals new genetic culprit in deadly skin cancer Drawing on the power of DNA sequencing, National Institutes of Health researchers have identified a new group of genetic mutations involved in the deadliest form of skin cancer, melanoma. 2 software tools that improve identification of cancer biomarkers earn certification The explosive growth of genomic and proteomic data has ushered in a new era of molecular medicine in which cancer detection, diagnosis and treatment are tailored to each individual's molecular profile. Human cells secrete cancer-killing protein, UK study finds Human cells are able to secrete a cancer-killing protein, scientists at the University of Kentucky's Markey Cancer Center have found. New technique could sustain cancer patients' fertility Researchers funded by the National Institutes of Health have completed a critical first step in the eventual development of a technique to retain fertility in women with cancer who require treatments that might otherwise make them unable to have children. New technique could save cancer patients' fertility The tiny translucent egg nestled in the special laboratory gel was a mere 30 days old, but its four-week birthday caused researchers to quietly celebrate. Report: Prostate cancer screening has yet to prove its worth The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small. Can we afford the cancer care of the future? When a cancer patient and his or her doctor discuss the value of a treatment option, the conversation usually centers on a consideration of the treatment's medical benefits versus its possible side effects for the patient. Younger men with advanced prostate cancer have shorter survival times While young men with prostate cancer have a low risk of dying early, those with advanced forms of cancer do not live as long as older men with similar forms of the disease. New universal breast cancer marker predicts recurrence and clinical outcome Reporting online in the American Journal of Pathology, researchers from the Kimmel Cancer Center at Jefferson have implicated the loss of a stromal protein called caveolin-1 as a major new prognostic factor in patients with breast cancer, predicting early disease recurrence, metastasis and breast cancer patient survival. Drugs needed to preserve eggs for reproduction need to be given in stages Cryoprotectants needed to preserve eggs for reproduction need to be given in stages, albeit rapid ones, say scientists who have developed a mathematical model that predicts optimal time for loading and unloading these drugs. More Cancer Patient Current Events and Cancer Patient News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||